Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Ischemic Heart Disease

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 124 articles: HTML format Text format

Single Articles

August 2019
1. CREA F, Montone RA, Niccoli G
   Myocardial infarction with non-obstructive coronary atherosclerosis: dealing with pears and apples.
   Eur Heart J. 2019 Aug 3. pii: 5543490. doi: 10.1093.
   PubMed     Text format    
   
   
   July 2019
2. ODER D, Topp MS, Nordbeck P
   Coronary B-cell lymphoma infiltration causing myocardial infarction.
   Eur Heart J. 2019 Jul 31. pii: 5542062. doi: 10.1093.
   PubMed     Text format    
   
   
   
3. FRANGOGIANNIS NG
   S100A8/A9 as a therapeutic target in myocardial infarction: cellular mechanisms, molecular interactions, and translational challenges.
   Eur Heart J. 2019 Jul 23. pii: 5537337. doi: 10.1093.
   PubMed     Text format    
   
   
   
4. MARINKOVIC G, Grauen Larsen H, Yndigegn T, Szabo IA, et al
   Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction.
   Eur Heart J. 2019 Jul 10. pii: 5530698. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
5. THIELE H, Ohman EM, de Waha-Thiele S, Zeymer U, et al
   Management of cardiogenic shock complicating myocardial infarction: an update 2019.
   Eur Heart J. 2019 Jul 4. pii: 5528526. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   June 2019
6. 
   Corrigendum to: Ephemeral Coronary Heart Disease.
   Eur Heart J. 2019 Jun 29. pii: 5530690. doi: 10.1093.
   PubMed     Text format    
   
   
   
7. THYGESEN K, Jaffe AS
   Should myocardial infarction type 2 be regarded as two separate entities?
   Eur Heart J. 2019 Jun 26. pii: 5523696. doi: 10.1093.
   PubMed     Text format    
   
   
   
8. MESSERLI FH
   Ephemeral Coronary Heart Disease.
   Eur Heart J. 2019;40:1906-1908.
   PubMed     Text format    
   
   
   
9. DREYER RP, Tavella R, Curtis JP, Wang Y, et al
   Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population.
   Eur Heart J. 2019 Jun 21. pii: 5521361. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
10. WHITE HD
    Adjunctive antithrombotic therapy with primary percutaneous coronary intervention in ST elevation myocardial infarction: ATOLL in perspective.
    Eur Heart J. 2019;40:e4-e7.
    PubMed     Text format    
    
    
    
11. ZENG L, Ntalla I, Kessler T, Kastrati A, et al
    Genetically modulated educational attainment and coronary disease risk.
    Eur Heart J. 2019 Jun 6. pii: 5512096. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
12. LI Z, Solomonidis EG, Meloni M, Taylor RS, et al
    Single-cell transcriptome analyses reveal novel targets modulating cardiac neovascularization by resident endothelial cells following myocardial infarction.
    Eur Heart J. 2019 Jun 4. pii: 5510786. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
13. ROHDE D, Nahrendorf M
    Clonal and diverse: revisiting cardiac endothelial cells after myocardial infarction.
    Eur Heart J. 2019 Jun 4. pii: 5510784. doi: 10.1093.
    PubMed     Text format    
    
    
    May 2019
14. LEMKES JS, Janssens GN, van Royen N
    ST-resolution and spontaneous reperfusion in patients with transient ST-segment elevation myocardial infarction.
    Eur Heart J. 2019 May 29. pii: 5506052. doi: 10.1093.
    PubMed     Text format    
    
    
    
15. WHITE HD, Steg PG, Szarek M, Bhatt DL, et al
    Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial.
    Eur Heart J. 2019 May 23. pii: 5497814. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
16. NISHI T, Funabashi N, Fujimoto Y, Kobayashi Y, et al
    Simultaneous anterior and inferior myocardial infarction in a patient with a single coronary artery anomaly.
    Eur Heart J. 2019 May 3. pii: 5485104. doi: 10.1093.
    PubMed     Text format    
    
    
    
17. GATZOULIS KA, Tsiachris D, Arsenos P, Antoniou CK, et al
    Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study.
    Eur Heart J. 2019 May 3. pii: 5485105. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    April 2019
18. HU C, Tkebuchava T, Hu D
    Managing acute myocardial infarction in China.
    Eur Heart J. 2019;40:1179-1181.
    PubMed     Text format    
    
    
    March 2019
19. BEN-YEHUDA O, Chen S, Redfors B, McAndrew T, et al
    Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
    Eur Heart J. 2019 Mar 28. pii: 5421317. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
20. HERRING N, Tapoulal N, Kalla M, Ye X, et al
    Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction.
    Eur Heart J. 2019 Mar 11. pii: 5374846. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
21. CHEN K, Breitner S, Wolf K, Hampel R, et al
    Temporal variations in the triggering of myocardial infarction by air temperature in Augsburg, Germany, 1987-2014.
    Eur Heart J. 2019 Mar 11. pii: 5374842. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
22. YOSHIDA R, Takagi K, Morita Y, Morishima I, et al
    Incidentally discovered left ventricular pseudoaneurysm after silent myocardial infarction occurred in a young woman with peritoneal dialysis.
    Eur Heart J. 2019 Mar 11. pii: 5374728. doi: 10.1093.
    PubMed     Text format    
    
    
    
23. SEHESTED TSG, Carlson N, Hansen PW, Gerds TA, et al
    Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction.
    Eur Heart J. 2019 Mar 9. pii: 5372329. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
24. REDFORS B, Dworeck C, Haraldsson I, Angeras O, et al
    Pretreatment with P2Y12 receptor antagonists in ST-elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry.
    Eur Heart J. 2019 Mar 9. pii: 5372330. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
25. RABER L, Yamaji K, Kelbaek H, Engstrom T, et al
    Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial inf
    Eur Heart J. 2019 Mar 9. pii: 5372331. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    February 2019
26. HECHT HS, Shaw L, Chandrashekhar YS, Bax JJ, et al
    Should NICE guidelines be universally accepted for the evaluation of stable coronary disease? A debate.
    Eur Heart J. 2019 Feb 27. pii: 5366197. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
27. WITASSEK F, Radovanovic D, Erne P, Puhan M, et al
    Mortality with antidepressants after acute MI: Antidepressant use after acute myocardial infarction (MI) is associated with an increased mortality 1 year after discharge from Swiss hospitals.
    Eur Heart J. 2019;40:410.
    PubMed     Text format    
    
    
    January 2019
28. CHEN S, Stone GW
    Circadian influences, time of hospitalization, and prognosis in acute myocardial infarction.
    Eur Heart J. 2019 Jan 30. pii: 5304404. doi: 10.1093.
    PubMed     Text format    
    
    
    
29. WU J, Hall M, Dondo TB, Wilkinson C, et al
    Association between time of hospitalization with acute myocardial infarction and in-hospital mortality.
    Eur Heart J. 2019 Jan 29. pii: 5301310. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
30. VACCARINO V, Badimon L, Bremner JD, Cenko E, et al
    Depression and coronary heart disease: 2018 ESC position paper of the working group of coronary pathophysiology and microcirculation developed under the auspices of the ESC Committee for Practice Guidelines.
    Eur Heart J. 2019 Jan 28. pii: 5303703. doi: 10.1093.
    PubMed     Text format    
    
    
    
31. THYGESEN K
    'Ten Commandments' for the Fourth Universal Definition of Myocardial Infarction 2018.
    Eur Heart J. 2019;40:226.
    PubMed     Text format    
    
    
    December 2018
32. RESOR CD, Bhatt DL
    Bioresorbable vascular scaffolds in acute myocardial infarction: non-inferior or not enough data?
    Eur Heart J. 2018 Dec 18. pii: 5251899. doi: 10.1093.
    PubMed     Text format    
    
    
    
33. BYRNE RA, Alfonso F, Schneider S, Maeng M, et al
    Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction
    Eur Heart J. 2018 Dec 5. pii: 5231946. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    November 2018
34. SHARMA S, Malhotra A
    Exercise testing and coronary disease: pushing fitness to higher peaks.
    Eur Heart J. 2018 Nov 29. pii: 5193507. doi: 10.1093.
    PubMed     Text format    
    
    
    
35. LETNES JM, Dalen H, Vesterbekkmo EK, Wisloff U, et al
    Peak oxygen uptake and incident coronary heart disease in a healthy population: the HUNT Fitness Study.
    Eur Heart J. 2018 Nov 29. pii: 5193503. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
36. XIN Y, Chen X, Hu W
    Oxygen therapy in ST-elevation myocardial infarction.
    Eur Heart J. 2018 Nov 28. pii: 5212709. doi: 10.1093.
    PubMed     Text format    
    
    
    
37. POLIMENI A, Spaccarotella C, Mongiardo A, Indolfi C, et al
    Myocardial infarction after dog bite.
    Eur Heart J. 2018 Nov 28. pii: 5212711. doi: 10.1093.
    PubMed     Text format    
    
    
    
38. BERGMARK BA, Faxon DP
    Transient ST-segment myocardial infarction: a new category of high risk acute coronary syndrome?
    Eur Heart J. 2018 Nov 15. pii: 5184544. doi: 10.1093.
    PubMed     Text format    
    
    
    
39. THYGESEN K
    What's new in the Fourth Universal Definition of Myocardial infarction?
    Eur Heart J. 2018;39:3757-3758.
    PubMed     Text format    
    
    
    
40. ELNABAWI YA, Dey AK, Mehta NN
    Emerging Applications of Coronary CT Angiography in Coronary Heart Disease: Getting Better with Time.
    Eur Heart J. 2018;39:3682-3684.
    PubMed     Text format    
    
    
    October 2018
41. FARAG M, Spinthakis N, Gue YX, Srinivasan M, et al
    Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study.
    Eur Heart J. 2018 Oct 30. pii: 5149701. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
42. LEMKES JS, Janssens GN, van der Hoeven NW, van de Ven PM, et al
    Timing of revascularization in patients with transient ST-segment elevation myocardial infarction: a randomized clinical trial.
    Eur Heart J. 2018 Oct 26. pii: 5145843. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
43. HERITIER H, Vienneau D, Foraster M, Eze IC, et al
    A systematic analysis of mutual effects of transportation noise and air pollution exposure on myocardial infarction mortality: a nationwide cohort study in Switzerland.
    Eur Heart J. 2018 Oct 24. pii: 5144026. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
44. WALLENTIN L
    Different perspectives on outcomes in patients with non-ST-elevation myocardial infarction when observed in clinical trials and in real life.
    Eur Heart J. 2018 Oct 17. pii: 5137113. doi: 10.1093.
    PubMed     Text format    
    
    
    September 2018
45. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
    Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014.
    Eur Heart J. 2018 Sep 19. pii: 5103432. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
46. HALL M, Bebb OJ, Dondo TB, Yan AT, et al
    Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction.
    Eur Heart J. 2018 Sep 7. pii: 5092654. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
47. MONTONE RA, Niccoli G, Lanza GA, Crea F, et al
    Reconsidering aetiologies of type 2 myocardial infarction: when a classification is a simplistic approach for a complex reality.
    Eur Heart J. 2018 Sep 6. pii: 5091846. doi: 10.1093.
    PubMed     Text format    
    
    
    
48. NESTELBERGER T, Boeddinghaus J, Mueller C
    Type 2 myocardial infarction.
    Eur Heart J. 2018 Sep 6. pii: 5091844. doi: 10.1093.
    PubMed     Text format    
    
    
    August 2018
49. BOEDDINGHAUS J, Nestelberger T, Twerenbold R, Neumann JT, et al
    Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction.
    Eur Heart J. 2018 Aug 29. pii: 5086724. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
50. THYGESEN K, Alpert JS, Jaffe AS, Chaitman BR, et al
    Fourth universal definition of myocardial infarction (2018).
    Eur Heart J. 2018 Aug 25. pii: 5079081. doi: 10.1093.
    PubMed     Text format    
    
    
    
51. SHIMONO H, Kajiya T, Atsuchi Y, Atsuchi N, et al
    Giant left ventricular pseudo-aneurysm after posterior myocardial infarction.
    Eur Heart J. 2018 Aug 21. pii: 5077320. doi: 10.1093.
    PubMed     Text format    
    
    
    July 2018
52. LUSCHER TF
    Performance of modern stents in stable and acute coronary disease.
    Eur Heart J. 2018;39:2435-2438.
    PubMed     Text format    
    
    
    June 2018
53. SAITO S, Krucoff MW, Nakamura S, Mehran R, et al
    Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-elu
    Eur Heart J. 2018 Jun 21. pii: 5042208. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
54. HOFMANN R, Witt N, Lagerqvist B, Jernberg T, et al
    Oxygen therapy in ST-elevation myocardial infarction.
    Eur Heart J. 2018 Jun 14. pii: 5037999. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    May 2018
55. MONTONE RA, Niccoli G, Lanza GA, Crea F, et al
    Personalized treatment of myocardial infarction and non-obstructive coronary arteries: an unmet need in a high-risk population.
    Eur Heart J. 2018 May 29. pii: 5020746. doi: 10.1093.
    PubMed     Text format    
    
    
    
56. IBANEZ B, Halvorsen S, Roffi M, Bueno H, et al
    Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force.
    Eur Heart J. 2018 May 29. pii: 5020748. doi: 10.1093.
    PubMed     Text format    
    
    
    
57. JANSSENS SP, Bogaert J, Zalewski J, Toth A, et al
    Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial.
    Eur Heart J. 2018 May 24. pii: 5003325. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    April 2018
58. MAHMOUD KD, Jolly SS, James S, Dzavik V, et al
    Clinical impact of direct stenting and interaction with thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Thrombectomy Trialists Collaboration.
    Eur Heart J. 2018 Apr 21. pii: 4975836. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    March 2018
59. AUFFRET V, Cottin Y, Leurent G, Gilard M, et al
    Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.
    Eur Heart J. 2018 Mar 15. pii: 4938779. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
60. DAI J, Xing L, Jia H, Zhu Y, et al
    In vivo predictors of plaque erosion in patients with ST-segment elevation myocardial infarction: a clinical, angiographical, and intravascular optical coherence tomography study.
    Eur Heart J. 2018 Mar 13. pii: 4934156. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    February 2018
61. THYGESEN K, Jaffe AS
    The prognostic impact of periprocedural myocardial infarction and injury.
    Eur Heart J. 2018 Feb 26. pii: 4911112. doi: 10.1093.
    PubMed     Text format    
    
    
    
62. QAYYUM F, Lauridsen BK, Frikke-Schmidt R, Kofoed KF, et al
    Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease.
    Eur Heart J. 2018 Feb 23. pii: 4907930. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
63. 
    euro6.5 million award to study impact of ECMO on myocardial infarction patients.
    Eur Heart J. 2018;39:649.
    PubMed     Text format    
    
    
    
64. WIJNS W, Naber CK
    Reperfusion delay in patients with high-risk ST-segment elevation myocardial infarction: every minute counts, much more than suspected.
    Eur Heart J. 2018 Feb 14. pii: 4855285. doi: 10.1093.
    PubMed     Text format    
    
    
    
65. SCHOLZ KH, Maier SKG, Maier LS, Lengenfelder B, et al
    Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.
    Eur Heart J. 2018 Feb 14. pii: 4855284. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    January 2018
66. ZEITOUNI M, Silvain J, Guedeney P, Kerneis M, et al
    Periprocedural myocardial infarction and injury in elective coronary stenting.
    Eur Heart J. 2018 Jan 20. pii: 4815728. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
67. LUSCHER TF
    ST-segment elevation myocardial infarction: the new ESC Guidelines.
    Eur Heart J. 2018;39:75-78.
    PubMed     Text format    
    
    
    
68. KIM K, Park SM, Lee K
    Weight gain after smoking cessation does not modify its protective effect on myocardial infarction and stroke: evidence from a cohort study of men.
    Eur Heart J. 2018 Jan 6. pii: 4791953. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    December 2017
69. KOENIG T, Sedding DG, Wester HJ, Derlin T, et al
    Seeing the unseen: post-infarction inflammation in an isolated right ventricular myocardial infarction visualized by combined cardiac magnetic resonance imaging and chemokine receptor CXCR4-targeted molecular imaging.
    Eur Heart J. 2017 Dec 27. pii: 4780241. doi: 10.1093.
    PubMed     Text format    
    
    
    
70. MONTONE RA, Niccoli G, Fracassi F, Russo M, et al
    Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests.
    Eur Heart J. 2017 Dec 8. pii: 4710061. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    November 2017
71. KUBO T, Shinke T, Okamura T, Hibi K, et al
    Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results.
    Eur Heart J. 2017;38:3139-3147.
    PubMed     Text format     Abstract available
    
    
    October 2017
72. KIM MK, Han K, Kim HS, Park YM, et al
    Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study.
    Eur Heart J. 2017 Oct 21. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
73. THYGESEN K, Jaffe AS
    Detecting myocardial infarction type 2: targetting the right patients.
    Eur Heart J. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format    
    
    
    
74. MANIWA N, Fujino M, Nakai M, Nishimura K, et al
    Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarction.
    Eur Heart J. 2017 Oct 3. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    September 2017
75. KIVIMAKI M, Nyberg ST, Batty GD, Kawachi I, et al
    Long working hours as a risk factor for atrial fibrillation: a multi-cohort study.
    Eur Heart J. 2017;38:2621-2628.
    PubMed     Text format     Abstract available
    
    
    August 2017
76. KOJIMA S, Michikawa T, Ueda K, Sakamoto T, et al
    Asian dust exposure triggers acute myocardial infarction.
    Eur Heart J. 2017 Aug 29. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
77. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
    Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.
    Eur Heart J. 2017 Aug 29. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
78. IBANEZ B, James S, Agewall S, Antunes MJ, et al
    2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European S
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed     Text format    
    
    
    
79. ESCANED J, Collet C, Ryan N, Luigi De Maria G, et al
    Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
80. LASSALE C, Tzoulaki I, Moons KGM, Sweeting M, et al
    Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis.
    Eur Heart J. 2017 Aug 14. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
81. NEUMANN JT, Sorensen NA, Rubsamen N, Ojeda F, et al
    Discrimination of patients with type 2 myocardial infarction.
    Eur Heart J. 2017 Aug 13. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
82. D'ASCENZO F, Iannaccone M, Saint-Hilary G, Bertaina M, et al
    Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients.
    Eur Heart J. 2017 Aug 11. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
83. KHAN AR, Golwala H, Tripathi A, Bin Abdulhak AA, et al
    Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis.
    Eur Heart J. 2017 Aug 7. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    July 2017
84. DE WAHA S, Patel MR, Granger CB, Ohman EM, et al
    Relationship between microvascular obstruction and adverse events following primary primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials.
    Eur Heart J. 2017 Jul 28. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
85. VRANCKX P, Windecker S, Welsh RC, Valgimigli M, et al
    Thrombo-embolic prevention after transcatheter aortic valve implantation.
    Eur Heart J. 2017 Jul 25. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
86. HOPEWELL JC, Malik R, Valdes-Marquez E, Worrall BB, et al
    Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke.
    Eur Heart J. 2017 Jul 17. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
87. POTHINENI NVK, Subramany S, Kuriakose K, Shirazi LF, et al
    Infections, atherosclerosis, and coronary heart disease.
    Eur Heart J. 2017 Jul 12. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    May 2017
88. ZITTERMANN A, Ernst JB, Prokop S, Fuchs U, et al
    Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily.
    Eur Heart J. 2017 May 12. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    April 2017
89. SINGH-MANOUX A, Fayosse A, Sabia S, Canonico M, et al
    Atrial fibrillation as a risk factor for cognitive decline and dementia.
    Eur Heart J. 2017 Apr 29. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
90. VRANCKX P, Frigoli E, Rothenbuhler M, Tomassini F, et al
    Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation.
    Eur Heart J. 2017;38:1069-1080.
    PubMed     Text format     Abstract available
    
    
    
91. GABET A, Danchin N, Juilliere Y, Olie V, et al
    Acute coronary syndrome in women: rising hospitalizations in middle-aged French women, 2004-14.
    Eur Heart J. 2017;38:1060-1065.
    PubMed     Text format     Abstract available
    
    
    
92. PALMERINI T, Della Riva D, Benedetto U, Bacchi Reggiani L, et al
    Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.
    Eur Heart J. 2017;38:1034-1043.
    PubMed     Text format     Abstract available
    
    
    
93. GEBHARD C
    Women and acute coronary syndromes: still up to no good.
    Eur Heart J. 2017;38:1066-1068.
    PubMed     Text format    
    
    
    
94. ONUMA Y, Serruys PW
    Freedom from long DAPT signals the demise of the bare-metal stent.
    Eur Heart J. 2017;38:970-973.
    PubMed     Text format    
    
    
    
95. CARLSSON M
    The impacts on healthcare when coronary angiography as the reference method for diagnostic accuracy of coronary artery disease is replaced by fractional flow reserve!
    Eur Heart J. 2017;38:999-1001.
    PubMed     Text format    
    
    
    March 2017
96. LI XS, Obeid S, Klingenberg R, Gencer B, et al
    Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
    Eur Heart J. 2017;38:814-824.
    PubMed     Text format     Abstract available
    
    
    
97. JIA H, Dai J, Hou J, Xing L, et al
    Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study).
    Eur Heart J. 2017;38:792-800.
    PubMed     Text format     Abstract available
    
    
    February 2017
98. LYALL DM, Celis-Morales CA, Anderson J, Gill JM, et al
    Associations between single and multiple cardiometabolic diseases and cognitive abilities in 474 129 UK Biobank participants.
    Eur Heart J. 2017;38:577-583.
    PubMed     Text format     Abstract available
    
    
    
99. MORTENSEN MB, Nordestgaard BG, Afzal S, Falk E, et al
    ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study.
    Eur Heart J. 2017;38:586-594.
    PubMed     Text format     Abstract available
    
    
    
100. DEFILIPPIS AP, Young R, McEvoy JW, Michos ED, et al
     Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern
     Eur Heart J. 2017;38:598-608.
     PubMed     Text format     Abstract available
     
     
     
101. SHUN-SHIN MJ, Zheng SL, Cole GD, Howard JP, et al
     Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials.
     Eur Heart J. 2017 Feb 21. doi: 10.1093.
     PubMed     Text format     Abstract available
     
     
     
102. ODAKA Y, Takahashi J, Tsuburaya R, Nishimiya K, et al
     Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries.
     Eur Heart J. 2017;38:489-496.
     PubMed     Text format     Abstract available
     
     
     
103. KARAKAS M, Schulte C, Appelbaum S, Ojeda F, et al
     Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study.
     Eur Heart J. 2017;38:516-523.
     PubMed     Text format     Abstract available
     
     
     
104. MOTWANI M, Dey D, Berman DS, Germano G, et al
     Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis.
     Eur Heart J. 2017;38:500-507.
     PubMed     Text format     Abstract available
     
     
     
105. PRIES AR, Reglin B
     Coronary microcirculatory pathophysiology: can we afford it to remain a black box?
     Eur Heart J. 2017;38:478-488.
     PubMed     Text format     Abstract available
     
     
     
106. NIELSEN LH, Botker HE, Sorensen HT, Schmidt M, et al
     Prognostic assessment of stable coronary artery disease as determined by coronary computed tomography angiography: a Danish multicentre cohort study.
     Eur Heart J. 2017;38:413-421.
     PubMed     Text format     Abstract available
     
     
     
107. VAN DER VALK FM, Kuijk C, Verweij SL, Stiekema LCA, et al
     Increased haematopoietic activity in patients with atherosclerosis.
     Eur Heart J. 2017;38:425-432.
     PubMed     Text format     Abstract available
     
     
     
108. BOURANTAS CV, Jaffer FA, Gijsen FJ, van Soest G, et al
     Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology.
     Eur Heart J. 2017;38:400-412.
     PubMed     Text format     Abstract available
     
     
     
109. LEIPSIC J, Blanke P
     Prognostic value of coronary CT angiography: lessons from the West Denmark Cardiac Registry.
     Eur Heart J. 2017;38:422-424.
     PubMed     Text format    
     
     
     
110. CIMATO TR
     Persistent stem cell-driven inflammation in patients with prior MI and stroke.
     Eur Heart J. 2017;38:433-435.
     PubMed     Text format    
     
     
     December 2016
111. BARTUNEK J, Terzic A, Davison BA, Filippatos GS, et al
     Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.
     Eur Heart J. 2016 Dec 23. pii: ehw543. doi: 10.1093.
     PubMed     Text format     Abstract available
     
     
     
112. PELLICANO M, De Bruyne B, Toth GG, Casselman F, et al
     Fractional flow reserve to guide and to assess coronary artery bypass grafting.
     Eur Heart J. 2016 Dec 23. pii: ehw505. doi: 10.1093.
     PubMed     Text format     Abstract available
     
     
     November 2016
113. RYAN N, Escaned J
     Myocardial bridge as a cause of persistent post percutaneous coronary intervention angina identified with exercise intracoronary physiology.
     Eur Heart J. 2016.
     PubMed     Text format    
     
     
     October 2016
114. CREA F, Bairey Merz CN, Beltrame JF, Kaski JC, et al
     The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift.
     Eur Heart J. 2016.
     PubMed     Text format    
     
     
     
115. ALFONSO F, Rivero F
     Coronary revascularization in diabetic patients with chronic kidney disease.
     Eur Heart J. 2016.
     PubMed     Text format    
     
     
     September 2016
116. JORGE C, Hiltrop N, Desmet W
     Heart failure with preserved ejection fraction: blame the veins....
     Eur Heart J. 2016.
     PubMed     Text format    
     
     
     
117. KOYAMA M, Yano T, Kikuchi K, Nagahara D, et al
     Lethal heart failure with anti-mitochondrial antibody: an arrhythmogenic right ventricular cardiomyopathy mimetic.
     Eur Heart J. 2016.
     PubMed     Text format    
     
     
     August 2016
118. YAMAJI K, Raber L, Zanchin T, Spitzer E, et al
     Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial.
     Eur Heart J. 2016.
     PubMed     Text format     Abstract available
     
     
     
119. BABER U, Farkouh ME, Arbel Y, Muntner P, et al
     Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease.
     Eur Heart J. 2016.
     PubMed     Text format     Abstract available
     
     
     
120. EISEN A, Cannon CP, Blazing MA, Bohula EA, et al
     The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial.
     Eur Heart J. 2016.
     PubMed     Text format     Abstract available
     
     
     June 2016
121. HEIDBUCHEL H, Verhamme P, Alings M, Antz M, et al
     Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.
     Eur Heart J. 2016.
     PubMed     Text format     Abstract available
     
     
     May 2016
122. PONIKOWSKI P, Voors AA, Anker SD, Bueno H, et al
     2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contributio
     Eur Heart J. 2016.
     PubMed     Text format    
     
     
     April 2016
123. MADONNA R, Van Laake LW, Davidson SM, Engel FB, et al
     Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.
     Eur Heart J. 2016.
     PubMed     Text format     Abstract available
     
     
     February 2016
124. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
     Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
     Eur Heart J. 2016.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: